# The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

> **NCT04768868** · PHASE1 · UNKNOWN · sponsor: **Impact Therapeutics, Inc.** · enrollment: 350 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** IMP7068

## Key facts

- **NCT ID:** NCT04768868
- **Lead sponsor:** Impact Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-25
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2023-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04768868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04768868, "The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04768868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*